Find the latest news from our company.
Nutraceutical companies and consumers in Argentina and Chile can now benefit from a complete system solution that encompasses Evonik’s formulation know-how, its EUDRAGUARD® coatings for nutraceuticals, and the AvailOm® platform. ... MORE
Evonik is transforming its Health Care business to maximize customer centricity and market focus. Effective April 1, 2022, the company will streamline its operations into three new product lines: Drug Delivery & Product, Drug Substance, and Health Solutions. ... MORE
Effective April 1, 2022, Evonik’s Health Care business line will be implementing a price increase of up to 45 percent across the portfolio of products, technologies, and services for pharmaceutical, nutraceutical and medical device markets. ... MORE
EUDRATEC® SoluFlow, a new microparticle technology for solubility enhancement of APIs, overcomes solubility hurdles that cannot be resolved by existing manufacturing technologies. ... MORE
Plant-derived cholesterol is one of the most critical components for the manufacture of mRNA vaccines and gene therapies. The large-scale production of PhytoChol® in Hanau, Germany, will meet an increased market demand for cholesterol. ... MORE
Evonik hat am Produktionsstandort Hanau neue Kapazitäten zur Herstellung von pflanzlichem Cholesterol aufgebaut, um die steigende Nachfrage der Industrie nach nicht-tierischem Cholesterol zu bedienen. ... MORE
